Target intelligence / Profile preview

RNA, 7SK small nuclear pseudogene 177 (RN7SKP177)

Target
RN7SKP177
Molecular classification
Other (Pseudogene; not an active receptor, enzyme, transcription factor, or channel[5][12].)
01

Overview

RNA, 7SK small nuclear pseudogene 177 (RN7SKP177) is a noncoding RNA pseudogene and part of a dispersed pseudogene family homologous to 7SK snRNA, a well-characterized regulatory noncoding RNA component of the 7SK nuclear ribonucleoprotein complex[5][12]. While the functional RN7SK snRNA controls transcriptional elongation and influences cell differentiation, RN7SKP177 lacks evidence of biological activity, protein-coding capacity, or known involvement in cellular processes or disease states[5][12]. Pseudogenes typically arise from gene duplication, retrotransposition, or genomic rearrangements and generally do not serve as molecular targets for drug development[5][12][9]. RN7SKP177 is annotated in gene databases but does not encode a functional molecule. If the query intended the functional 7SK snRNA (RN7SK) rather than this pseudogene, there would be therapeutic, immunological, and transcriptional regulatory relevance[2][4][7][9]. However, as written ("RN7SKP177"), the entry refers only to a pseudogene, and all established biological and clinical roles should be attributed to the actual 7SK snRNA locus rather than its pseudogenes[5][12].

Other names
RN7SKP177RNA, 7SK small nuclear pseudogene 1777SK pseudogene 177
02

Mechanism of action

None (No known drug mechanisms of action involving this pseudogene[5][12].)

03

Biological functions

None (No known direct biological function; pseudogenes generally do not code for active molecules and typically lack known roles unless characterized as regulatory RNAs in specific contexts[5][12][9].)
04

Disease associations

Other (No established disease associations; functional 7SK snRNA has disease relevance, but the pseudogene does not have a characterized role[5][12].)
05

Safety considerations

None (No therapeutic use; thus no safety concerns are known[5][12].)
06

Interacting drugs

None (No drugs known to interact with this pseudogene[5][12].)
07

Biomarkers

None (Not established as a biomarker for patient selection or efficacy monitoring[5][12].)

Beyond the preview

Go deeper on RNA, 7SK small nuclear pseudogene 177 (RN7SKP177).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 177 (RN7SKP177).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call